Skip to content

D&A at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$67.15M-44.2%
IQVIA logo
IQVIAIQV
$288M+8.7%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$155K-34.3%
Astrana Health logo
Astrana HealthASTH
$15.48M+126%
Labcorp Holdings logo
Labcorp HoldingsLH
$75.6M+8.6%
Flex Ltd. logo
Flex Ltd.FLEX
$16M-23.8%

Segments

By segment

See full
Clinical Services Segment$5.2M+4.0%

Other financials

Income statement

See full
Revenue$636.5M-2.3%
Gross profit$123.6M+6.1%
Operating income-$3.4M+99.3%
Net income-$23.6M+95.8%
EPS (diluted)-$0.25+96.0%

Balance sheet

See full
Cash & equivalents$147.5M+45.2%
Total debt$1.1B-13.1%
Total equity$525.9M-38.8%
Total assets$2.7B-14.0%

Cash flow

See full
Operating cash flow-$17.0M+86.3%
CapEx$8.0M+176%
Free cash flow-$25.0M+80.3%

Valuation

See full
Market cap$1.61B+29.3%
Enterprise value$2.58B-0.8%
P/S0.6×+0.1×

Profitability

See full
Gross margin18.9%-1.3pp
Operating margin-13.1%-4.1pp
Net margin-16.5%-5.0pp
FCF margin5.8%+1.7pp

Returns & leverage

See full
Return on equity-64.5%0.0pp
Debt / equity2.1×+0.6×
Current ratio0.9×0.0×

Where this comes from

Reported directly by Fortrea Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: Fortrea Holdings Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fortrea Holdings Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fortrea Holdings Inc.'s D&A?
Fortrea Holdings Inc. (FTRE) reported D&A of $19.8M in Q1 2026.
How has Fortrea Holdings Inc.'s D&A changed year-over-year?
Fortrea Holdings Inc.'s D&A increased by 1.5% year-over-year, from $19.5M to $19.8M.
What is the long-term trend for Fortrea Holdings Inc.'s D&A?
Over 4 years (2021 to 2025), Fortrea Holdings Inc.'s D&A has grown at a -17.2% compound annual growth rate (CAGR), from $166.3M to $78M.
What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.